1. Long term outcome of dental implants in childhood. Report of two cases. (October 2015) Authors: Paulus, C.; Martin, P. Journal: International journal of oral & maxillofacial surgery Issue: Volume 44(2015)Supplement 1 Page Start: e180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FINAL RESULTS OF CALGB 50803 (ALLIANCE): A PHASE 2 TRIAL OF LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA. (June 2017) Authors: Martin, P.; Jung, S.; Pitcher, B.; Bartlett, N.L.; Blum, K.A.; Shea, T.; Ruan, J.; Smith, S.E.; Leonard, J.P.; Cheson, B.D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study. (June 2017) Authors: Fowler, N.; Gopal, A.K.; Schuster, S.J.; Trotman, J.; Hess, G.; Hou, J.; Yacoub, A.; Lill, M.; Martin, P.; Vitolo, U.; Spencer, A.; Radford, J.; Jurczak, W.; Morton, J.; Osmanov, D.; Caballero, D.; Deshpande, S.; Vermeulen, J.; Damle, R.; Schaffer, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of runaway electron generation parameters in small, medium-sized and large tokamaks—A survey of experiments in COMPASS, TCV, ASDEX-Upgrade and JET. (8th November 2017) Authors: Plyusnin, V.V.; Reux, C.; Kiptily, V.G.; Pautasso, G.; Decker, J.; Papp, G.; Kallenbach, A.; Weinzettl, V.; Mlynar, J.; Coda, S.; Riccardo, V.; Lomas, P.; Jachmich, S.; Shevelev, A.E.; Alper, B.; Khilkevitch, E.; Martin, Y.; Dux, R.; Fuchs, C.; Duval, B. Other Names: collab.; collab.; collab.; collab.; collab. Journal: Nuclear fusion Issue: Volume 58:Number 1(2018:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Treatment of depression in adults with cancer: a systematic review of randomized controlled trials. Issue 5 (19th June 2013) Authors: Walker, J.; Sawhney, A.; Hansen, C. Holm; Ahmed, S.; Martin, P.; Symeonides, S.; Murray, G.; Sharpe, M. Journal: Psychological medicine Issue: Volume 44:Issue 5(2014) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Determining the economic value of daily dry matter intake and associated methane emissions in dairy cattle. (22nd July 2019) Authors: Richardson, C. M.; Baes, C. F.; Amer, P. R.; Quinton, C.; Martin, P.; Osborne, V. R.; Pryce, J. E.; Miglior, F. Journal: Animal Issue: Volume 14:Number 1(2020) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA EXPERIENCING FRONTLINE TREATMENT FAILURE: A MULTICENTER RETROSPECTIVE STUDY. (12th June 2019) Authors: Bond, D.A.; Switchenko, J.; Maddocks, K.; Churnetski, M.; Goyal, S.; Shanmugasundaram, K.; Calzada, O.; Kolla, B.; Bachanova, V.; Gerson, J.; Barta, S.; Hill, B.; Salwaha, Y.; Martin, P.; Maldonado, E.; Gordon, M.; Danilov, A.; Grover, N.; Mathews, S.; Burkart, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA. (12th June 2019) Authors: Ruan, J.; Leonard, J.P.; Coleman, M.; Rutherford, S.; Van Besien, K.; Rodriguez, A.; Benderoff, L.; Mehta‐Shah, N.; Moskowitz, A.; Sokol, L.; Cerchietti, L.; Inghirami, G.; Martin, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR). (12th June 2019) Authors: Hill, B.T.; Switchenko, J.M.; Martin, P.; Churnetski, M.C.; Sawalha, Y.; Goyal, S.; Shanmugasundaram, K.; Calzada, O.; Kolla, B.; Bachanova, V.; Gerson, J.N.; Barta, S.K.; Maldonado, E.; Gordon, M.; Danilov, A.; Grover, N.S.; Mathews, S.; Burkart, M.; Karmali, R.; Ghosh, N. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and efficacy of single‐agent ibrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): A multicenter, open‐label, phase 2 study. (June 2017) Authors: Collins, G.P.; Noy, A.; de Vos, S.; Thieblemont, C.; Martin, P.; Flowers, C.; Morschhauser, F.; Ma, S.; Coleman, M.; Peles, S.; Smith, S.; Barrientos, J.; Smith, A.; Munneke, B.; Dimery, I.; Beaupre, D.; Chen, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗